Ablation Technologies Market

Ablation Technologies Market (2011-2016) - (Cancer/tumor, Cardiac, Gynecology, Orthopedics, Radiofrequency, Cryoablation, Microwave, Hydrothermal, Radiation and Laser/ Light) - Global Trends & Competitive Analysis

Report Code: BT 1155 Dec, 2018, by marketsandmarkets.com

The global ablation technologies market consists of thermal and non- thermal ablation technologies. Under thermal ablation technologies, radiofrequency, microwave, ultrasound, hydrothermal, radiation, electrical and light/laser technologies are included, whereas non-thermal ablation technologies include cryoablation and hydromechanical. Ablation technologies have applications in various clinical areas such as cancer, cardiac, ophthalmology, urology, gynecology and orthopedics. Global ablation technologies market was valued at $7.5 billion in 2011 and is poised to grow at a CAGR of 10.5% to reach $12.4 billion by 2016.

A significant growth has been seen in the procedures of ablation in the recent years, which is largely driven by healthcare, demographic, and cost-effective factors. Increasing application in clinical areas such cancer and cardiac together, have contribute to this growth in ablation procedures.

The major driving factor for these markets would be the technological advancements and increasing demand for minimally invasive surgical procedures. In addition, Older population is growing in the mature markets such as Japan, U.S. and in the Western European countries. With increasing age, the risk of developing chronic diseases such as cancer, cardiovascular disorders, gynaecological, and orthopaedic problems increases. As the incidence cases of these chronic diseases continue to rise in the coming years, the ablation devices market for treating these diseases would show significant growth in the forecast period. The principal advantage of ablation procedures over surgery is short recovery time, short length scars, low risk of infection, minimal damage to the healthy tissue, less blood loss, and shorter hospital stays.

In 2011, radiation therapy contributed to over 41% of the total ablation technologies market. The major driver of radiation therapy is the fact that it is applicable to any form of cancer ranging from soft tissue such as liver, lungs to bone metastases. Unlike most other techniques, radiation therapy is considered to be effective in all cancer scenarios, thus it is a single treatment for control of cancer used by most radiologists. It is expected that, radiation therapy will continue to enjoy the majority share in the ablation technologies market for at least another decade owing to its broad scope of use, different methods of application, stable acceptance in population, and high level of awareness as compared to newly introduced ablation techniques such as hydrothermal, microwave and hydromechanical ablation.

Americas is the biggest market for ablation devices, followed by Europe. However, Asian countries represent the fastest growing markets and factors such as high patient pool, growing preferences to minimally invasive surgery, geographical expansion of market players, increased government investment in healthcare facilities especially in rural areas, westernization in life style and dietary habits, increasing healthcare expenditure & improving medical insurance plans, are driving the ablation devices market.

Ablation technologies market research report categorizes the global market on the basis of application, devices and market trends; competitive analysis. Report also includes company profiles of major players such as Accuray (U.S.), Alcon Laboratories Inc. (U.S.), AngioDynamics Inc. (U.S.), Arthrocare Corporation (U.S.), Atricure Inc. (U.S.), Biosense Webster (U.S.), Boston Scientific (U.S.), BSD Medical Corporation (U.S.), C.R. Bard Inc. (U.S.), Conmed Corporation (U.S.), Covidien (Ireland), Elekta AB ( Sweden), Galil Medical ltd. (Israel), Medtronic Inc. (U.S.), Misonix Inc. (U.S.), nContact Surgical Inc. (U.S.), Olympus Corporation (Japan), Smith & Nephew (U.K.), St. Jude Medical (U.S.), Urologix Inc. (U.S.) and Varian Medical Systems Inc. (U.S.).

Ablation procedure refers to a minimally invasive surgical procedure, which involves either destruction or removal of diseased or unnecessary tissue, with the aim to cure the disease. It provides successful form of surgical option that has gradually becoming a popular alternative over invasive procedure amongst physicians and patients. The principal advantage of these procedures over surgery is short recovery time, short length scars, low risk of infection, less blood loss, and shorter hospital stays.

Technological innovations in these ablation devices have been seen in the past years. Newer devices with better safety and efficacy attributes contribute to widespread adoption of the ablation procedures by physicians worldwide. Of all the ablation technologies, radiation technology is most widely used. Cancer and cardiac ablation are the major application areas and accounts for ~64% share in the ablation market. Cardiac ablation is considered as the burning issue in ablation devices industry as many market players are currently performing clinical trials on ablation devices in the cardiac segment and see a high growth opportunity in the coming future.

Rapid developments are taking place in the field of new irrigated catheters (which provide enhanced lesion formation along with more efficient cooling), force sensing catheters (for accurate determination of force applied on the tissue), multielectrode RF (to make complex lesion sets through a single application) and in radiometric temperature sensing catheter (to measure the temperature of heated tissue during ablation).

Patients and physicians are increasingly inclined towards the usage and reception of new ablation technologies due to the numerous advantages offered by these devices. In addition, industry players have identified the growth opportunities in the ablation devices market, and are in process to come up with more efficient innovations and developments in this field.

The penetration rate of minimally invasive surgical procedures and ablation techniques is faltering in the emerging markets. However, established companies and new entrants in the ablation devices market should consider these GDP growth rates, increasing procedural volumes and low penetration rates compared to mature markets, as the driving opportunistic factors that will plant the seed for future possible success for such companies.

 Ablation Technologies Market

Ablation Technology Market

Radiation accounted for major share in the thermal ablation technologies, where as cryoablation holds maximum share in non – thermal ablation technologies.

TABLE OF CONTENTS     
     
1 INTRODUCTION    
  1.1 KEY TAKE AWAYS    
  1.2 REPORT DESCRIPTION    
  1.3 MARKETS COVERED    
  1.4 STAKEHOLDERS    
  1.5 RESEARCH METHODOLOGY    
      1.5.1 MARKET SIZE    
      1.5.2 MARKET SHARE    
      1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES    
      1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES    
      1.5.5 ASSUMPTIONS    
     
2 EXECUTIVE SUMMARY    
     
3 MARKET OVERVIEW 
   
  3.1 INTRODUCTION    
  3.2 ABLATION TECHNOLOGIES MARKET    
  3.3 ABLATION APPLICATION MARKET    
  3.4 MARKET DYNAMICS    
      3.4.1 DRIVERS    
            3.4.1.1 Technological advancements    
            3.4.1.2 Increasing procedures through minimal invasive surgery    
            3.4.1.3 Increasing aging population with higher risk of chronic diseases    
      3.4.2 RESTRAINTS    
            3.4.2.1 Pricing and reimbursement issues    
            3.4.2.2 Increasing regulatory agencies pressures    
      3.4.3 OPPORTUNITIES & CHALLENGES    
            3.4.3.1 Emerging markets    
            3.4.3.2 Technical and educational challenges    
  3.5 BURNING ISSUES    
  3.5.1 INCREASING RESEARCH IN CARDIAC ABLATION    
  3.6 MARKET SHARE ANALYSIS    
     
4 ABLATION MARKET, BY TECHNOLOGY    
  4.1 INTRODUCTION    
  4.2 THERMAL    
      4.2.1 ELECTRICAL    
      4.2.2 RADIATION    
      4.2.3 RADIOFREQUENCY    
      4.2.4 LIGHT    
      4.2.5 ULTRASOUND    
      4.2.6 MICROWAVE    
      4.2.7 HYDROTHERMAL    
  4.3 NON-THERMAL    
      4.3.1 CRYOTHERAPY    
      4.3.2 HYDROMECHANICAL    
     
5 ABLATION TECHNOLOGY MARKET, BY PRODUCTS    
  5.1 ELECTRICAL    
      5.1.1 ELECTRICAL ABLATORS    
            5.1.1.1 Argon Plasma/Beam coagulators    
            5.1.1.2 Irreversible electroporation    
      5.1.2 ELECTRONIC BRACHYTHERAPY    
  5.2 RADIATION    
      5.2.1 BRACHYTHERAPY    
            5.2.1.1 High-Dose-Rate (HDR) brachytherapy    
            5.2.1.2 Pulsed-Dose-Rate brachytherapy    
            5.2.1.3 Permanent seed brachytherapy or Low-Dose-Rate (LDR) brachytherapy    
      5.2.2 STEREOTACTIC RADIOSURGERY & STEREOTACTIC RADIOTHERAPY    
      5.2.3 IMAGE GUIDED RADIATION THERAPY (IGRT)    
      5.2.4 INTENSITY-MODULATED RADIATION THERAPY (IMRT)    
      5.2.5 STEREOTACTIC BODY RADIATION THERAPY(SBRT)    
      5.2.6 PROTON BEAM THERAPY    
  5.3 RADIOFREQUENCY    
      5.3.1 TEMPERATURE CONTROLLED RADIOFREQUENCY ABLATION DEVICES    
      5.3.2 FLUID COOLED RF ABLATION    
      5.3.3 THE ROBOTIC CATHETER MANIPULATION SYSTEM    
  5.4 LIGHT/ LASER    
      5.4.1 COLD LASERS    
      5.4.2 EXCIMER LASERS    
  5.5 ULTRASOUND    
      5.5.1 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU)    
      5.5.2 MAGNETIC RESONANCE GUIDED ULTRASOUND MRGFUS    
      5.5.3 ULTRASONIC SURGICAL SYSTEMS    
      5.5.4 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY    
  5.6 MICROWAVE ABLATION    
      5.6.1 MICROWAVE THERMOTHERAPY    
  5.7 HYDROTHERMAL ABLATION    
      5.7.1 ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES    
  5.8 CRYOABLATION    
      5.8.1 TISSUE CONTACT PROBE    
      5.8.2 TISSUE SPRAY PROBE    
      5.8.3 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES    
     
6 ABLATION TECHNOLOGY MARKET, BY APPLICATIONS    
  6.1 INTRODUCTION    
  6.2 CANCER    
  6.3 CARDIOVASCULAR    
  6.4 OPHTHALMOLOGY    
  6.5 GYNECOLOGY    
  6.6 UROLOGY    
  6.7 ORTHOPEDICS    
  6.8 OTHERS    
     
7 GEOGRAPHICAL ANALYSIS    
  7.1 INTRODUCTION    
  7.2 AMERICAS    
  7.3 EUROPE    
  7.4 ASIA-PACIFIC    
  7.5 ROW    
     
8 COMPETITIVE LANDSCAPE    
  8.1 INTRODUCTION    
  8.2 MERGERS & ACQUISITIONS    
  8.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES    
  8.4 NEW PRODUCT LAUNCHES    
  8.5 PIPELINE DEVELOPMENTS    
  8.6 OTHER DEVELOPMENTS    
     
9 COMPANY PROFILES    
  9.1 ACCURAY INC.    
      9.1.1 OVERVIEW    
      9.1.2 FINANCIALS    
      9.1.3 PRODUCTS & SERVICES    
      9.1.4 STRATEGY    
      9.1.5 DEVELOPMENTS    
  9.2 ALCON LABORATORIES INC.    
      9.2.1 OVERVIEW    
      9.2.2 FINANCIALS    
      9.2.3 PRODUCTS & SERVICES    
      9.2.4 STRATEGY    
      9.2.5 DEVELOPMENTS    
  9.3 ANGIODYNAMICS INC.    
      9.3.1 OVERVIEW    
      9.3.2 FINANCIALS    
      9.3.3 PRODUCTS & SERVICES    
      9.3.4 STRATEGY    
      9.3.5 DEVELOPMENTS    
  9.4 ARTHROCARE CORPORATION    
      9.4.1 OVERVIEW    
      9.4.2 FINANCIALS    
      9.4.3 PRODUCTS & SERVICES    
      9.4.4 STRATEGY    
      9.4.5 DEVELOPMENTS    
  9.5 ATRICURE INC.    
      9.5.1 OVERVIEW    
      9.5.2 FINANCIALS    
      9.5.3 PRODUCTS & SERVICES    
      9.5.4 STRATEGY    
      9.5.5 DEVELOPMENTS    
  9.6 BIOSENSE WEBSTER INC.    
      9.6.1 OVERVIEW    
      9.6.2 PRODUCTS & SERVICES    
      9.6.3 STRATEGY    
      9.6.4 DEVELOPMENTS    
  9.7 BOSTON SCIENTIFIC CORPORATION    
      9.7.1 OVERVIEW    
      9.7.2 FINANCIALS    
      9.7.3 PRODUCTS & SERVICES    
      9.7.4 STRATEGY    
      9.7.5 DEVELOPMENTS    
  9.8 BSD MEDICAL CORPORATION    
      9.8.1 OVERVIEW    
      9.8.2 FINANCIALS    
      9.8.3 PRODUCTS & SERVICES    
      9.8.4 STRATEGY    
      9.8.5 DEVELOPMENTS    
  9.9 C.R. BARD INC.    
      9.9.1 OVERVIEW    
      9.9.2 FINANCIALS    
      9.9.3 PRODUCTS & SERVICES    
      9.9.4 STRATEGY    
      9.9.5 DEVELOPMENTS    
  9.10 CONMED CORPORATION    
      9.10.1 OVERVIEW    
      9.10.2 FINANCIALS    
      9.10.3 PRODUCTS & SERVICES    
      9.10.4 STRATEGY    
      9.10.5 DEVELOPMENTS    
  9.11 COVIDIEN PLC    
      9.11.1 OVERVIEW    
      9.11.2 FINANCIALS    
      9.11.3 PRODUCTS & SERVICES    
      9.11.4 STRATEGY    
      9.11.5 DEVELOPMENTS    
  9.12 ELEKTA AB    
      9.12.1 OVERVIEW    
      9.12.2 FINANCIALS    
      9.12.3 PRODUCTS & SERVICES    
      9.12.4 STRATEGY    
      9.12.5 DEVELOPMENTS    
  9.13 GALIL MEDICAL LTD.    
      9.13.1 OVERVIEW    
      9.13.2 FINANCIALS    
      9.13.3 PRODUCTS & SERVICES    
      9.13.4 STRATEGY    
      9.13.5 DEVELOPMENTS    
  9.14 MEDTRONIC INC.    
      9.14.1 OVERVIEW    
      9.14.2 FINANCIALS    
      9.14.3 PRODUCTS & SERVICES    
      9.14.4 STRATEGY    
      9.14.5 DEVELOPMENTS    
  9.15 MISONIX INC.    
      9.15.1 OVERVIEW    
      9.15.2 FINANCIALS    
      9.15.3 PRODUCTS & SERVICES    
      9.15.4 STRATEGY    
      9.15.5 DEVELOPMENTS    
  9.16 NCONTACT SURGICAL INC.    
      9.16.1 OVERVIEW    
      9.16.2 FINANCIALS    
      9.16.3 PRODUCTS & SERVICES    
      9.16.4 STRATEGY    
      9.16.5 DEVELOPMENTS    
  9.17 OLYMPUS CORPORATION    
      9.17.1 OVERVIEW    
      9.17.2 FINANCIALS    
      9.17.3 PRODUCTS & SERVICES    
      9.17.4 STRATEGY    
      9.17.5 DEVELOPMENTS    
  9.18 SMITH & NEPHEW    
      9.18.1 OVERVIEW    
      9.18.2 FINANCIALS    
      9.18.3 PRODUCTS & SERVICES    
      9.18.4 STRATEGY    
      9.18.5 DEVELOPMENTS    
  9.19 ST. JUDE MEDICAL INC.    
      9.19.1 OVERVIEW    
      9.19.2 FINANCIALS    
      9.19.3 PRODUCTS & SERVICES    
      9.19.4 STRATEGY    
      9.19.5 DEVELOPMENTS    
  9.20 UROLOGIX INC.    
      9.20.1 OVERVIEW    
      9.20.2 FINANCIALS    
      9.20.3 PRODUCTS & SERVICES    
      9.20.4 STRATEGY    
      9.20.5 DEVELOPMENTS    
  9.21 VARIAN MEDICAL SYSTEMS INC.
       9.21.1 OVERVIEW    
       9.21.2 FINANCIALS    
       9.21.3 PRODUCTS & SERVICES    
       9.21.4 STRATEGY    
       9.21.5 DEVELOPMENTS          
     
LIST OF TABLES     
     
TABLE 1 GLOBAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)    
TABLE 2 ABLATION TECHNOLOGIES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 3 GLOBAL THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 – 2016 ($MILLION)    
TABLE 4 THERMAL ABLATION TECHNOLOGIES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 5 ELECTRIC ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 6 RADIATION ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)\    
TABLE 7 RADIOFREQUENCY ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 8 LIGHT/LASER ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 9 ULTRASOUND ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 10 MICROWAVE ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 11 HYDROTHERMAL ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 12 GLOBAL NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 – 2016 ($MILLION)    
TABLE 13 NON-THERMAL ABLATION TECHNOLOGIES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 14 CRYOABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 15 HYDROMECHANICAL ABLATION TECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 16 GLOBAL ELECTRICAL ABLATION MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)    
TABLE 17 GLOBAL ELECTRICAL ABLATORS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)    
TABLE 18 GLOBAL ELECTRICAL ABLATION MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND)    
TABLE 19 GLOBAL ELECTRICAL ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 20 GLOBAL ELECTRICAL ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND)    
TABLE 21 ARGON PLASMA/BEAM COAGULATION ABLATION MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 22 ARGON PLASMA/BEAM COAGULATION ABLATION MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND)    
TABLE 23 IRREVERSIBLE ELECTROPORATION MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 24 IRREVERSIBLE ELECTROPORATION MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND)    
TABLE 25 ELECTRONIC BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 26 ELECTRONIC BRACHYTHERAPY MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016    
TABLE 27 GLOBAL RADIATION ABLATION PRODUCTS MARKET REVENUE, BY SEGMENTS, 2009 - 2016 ($MILLION)    
TABLE 28 GLOBAL RADIATION ABLATION PRODUCTS MARKET VOLUME, BY SEGMENTS, 2009 - 2016     
TABLE 29 GLOBAL RADIATION ABLATION PRODUCTS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 30 GLOBAL RADIATION ABLATION PRODUCTS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016    
TABLE 31 GLOBAL BRACHYTHERAPY MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)    
TABLE 32 GLOBAL BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 33 HIGH-DOSE-RATE (HDR) BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 34 PULSED-DOSE-RATE (PDR) BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 35 PERMANENT SEED BRACHYTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 36 STEREOTACTIC RADIOSURGERY (SRS) & STEREOTACTIC RADIOTHERAPY (SRT) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 37 STEREOTACTIC RADIOSURGERY (SRS) & STEREOTACTIC RADIOTHERAPY (SRT) MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016    
TABLE 38 IMAGE GUIDED RADIATION THERAPY (IGRT) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 39 IMAGE GUIDED RADIATION THERAPY (IGRT) MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016    
TABLE 40 INTENSITY-MODULATED RADIATION THERAPY (IMRT) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 41 INTENSITY-MODULATED RADIATION THERAPY (IMRT) MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016    
TABLE 42 STEREOTACTIC BODY RADIATION THERAPY (SBRT) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 43 STEREOTACTIC BODY RADIATION THERAPY (SBRT) MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016    
TABLE 44 PROTON BEAM THERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 45 PROTON BEAM THERAPY MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016    
TABLE 46 GLOBAL RADIOFREQUENCY ABLATORS MARKET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)    
TABLE 47 GLOBAL RADIOFREQUENCY ABLATORS MARKET VOLUME, BY SEGMENTS, 2009 - 2011 (THOUSAND)    
TABLE 48 GLOBAL RADIOFREQUENCY ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 49 GLOBAL RADIOFREQUENCY ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND)    
TABLE 50 TEMPERATURE CONTROLLED ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 51 TEMPERATURE CONTROLLED ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)    
TABLE 52 FLUID COOLED ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 53 FLUID COOLED ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)    
TABLE 54 CATHETER MANIPULATION SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 55 GLOBAL LIGHT/LASER ABLATORS MARKET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)    
TABLE 56 GLOBAL LIGHT/LASER ABLATORS MARKET VOLUME, BY SEGMENTS, 2009 - 2011 (THOUSAND)    
TABLE 57 LIGHT/LASER ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 58 LIGHT/LASER ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)    
TABLE 59 COLD LASER ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 60 COLD LASER ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2011 (THOUSAND)    
TABLE 61 EXCIMER LASER ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 62 EXCIMER LASER ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)    
TABLE 63 GLOBAL ULTRASOUND ABLATION PRODUCTS MARKET BY REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)    
TABLE 64 GLOBAL ULTRASOUND ABLATION PRODUCTS MARKET BY VOLUME, BY SEGMENTS, 2009 – 2011 (THOUSAND)    
TABLE 65 ULTRASOUND ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 66 ULTRASOUND ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2011 (THOUSAND)    
TABLE 67 HIGH INTENSITY FOCUSED (HIFU) ULTRASOUND ABLATORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 68 HIGH INTENSITY FOCUSED (HIFU) ULTRASOUND ABLATORS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011    
TABLE 69 MAGNETIC RESONANCE GUIDED ULTRASOUND ABLATORS (MRG-FUS) MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 70 MAGNETIC RESONANCE GUIDED ULTRASOUND ABLATORS (MRG-FUS) MARKET VOLUME, BY GEOGRAPHY, 2009 – 2011    
TABLE 71 ULTRASONIC SURGICAL SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 72 ULTRASONIC SURGICAL SYSTEMS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)    
TABLE 73 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL) SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 74 MICROWAVE THERMOTHERAPY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 75 HYDROTHERMAL BALLOON ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 76 HYDROTHERMAL BALLOON ABLATION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2009 - 2011 (THOUSAND)    
TABLE 77 GLOBAL CRYOABLATION MARKET REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)    
TABLE 78 GLOBAL CRYOABLATION MARKET VOLUME, BY SEGMENTS, 2009 - 2011    
TABLE 79 GLOBAL CRYOABLATION MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 80 GLOBAL CRYOABLATION MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016    
TABLE 81 TISSUE CONTACT PROBE CATHETER DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 82 TISSUE CONTACT PROBE CATHETER MARKET VOLUME, BY GEOGRAPHY, 2009 – 2011    
TABLE 83 TISSUE SPRAY PROBE CATHETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 84 TISSUE SPRAY PROBE CATHETER MARKET VOLUME, BY GEOGRAPHY, 2009 – 2011    
TABLE 85 EPIDERMAL & SUBCUTANEOUS CRYOABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)    
TABLE 86 GLOBAL ABLATION DEVICES MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)    
TABLE 87 FREQUENTLY USED THERAPIES FOR CANCER ABLATION    
TABLE 88 CANCER ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 89 CARDIOVASCULAR ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 90 OPHTHALMOLOGY ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 91 GYNECOLOGY ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 92 UROLOGY ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 93 ORTHOPEDICS ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 94 OTHER APPLICATIONS ABLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)    
TABLE 95 GLOBAL ABLATION TECHNOLOGIES MARKET, BY GEOGRAPHY, 2009 – 2016 ($MILLION)    
TABLE 96 AMERICAS: ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)    
TABLE 97 AMERICAS: THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)    
TABLE 98 AMERICAS: NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)    
TABLE 99 EUROPE: ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)    
TABLE 100 EUROPE: THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)    
TABLE 101 EUROPE: NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)    
TABLE 102 ASIA–PACIFIC: ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)    
TABLE 103 ASIA-PACIFIC: THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)    
TABLE 104 ASIA-PACIFIC: NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)    
TABLE 105 ROW: ABLATION MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)    
TABLE 106 ROW: THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)    
TABLE 107 ROW: NON-THERMAL ABLATION MARKET REVENUE, BY TECHNOLOGY, 2009 - 2016 ($MILLION)    
TABLE 108 MERGERS & ACQUISITIONS, JANUARY 2009 – APRIL 2012    
TABLE 109 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES, JANUARY 2009 – APRIL 2012    
TABLE 110 NEW PRODUCT LAUNCHES, JANUARY 2009 – APRIL 2012    
TABLE 111 PIPELINE DEVELOPMENTS, JANUARY 2009 – APRIL 2012    
TABLE 112 OTHER DEVELOPMENTS, JANUARY 2009 – APRIL 2012    
TABLE 113 ACCURAY INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 114 ACCURAY INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 115 ACCURAY INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 116 ALCON LABORATORIES INC.: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($MILLION)    
TABLE 117 ALCON LABORATORIES INC.: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)    
TABLE 118 ANGIODYNAMICS INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 119 ANGIODYNAMICS INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 120 ANGIODYNAMICS INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 121 ARTHROCARE CORP : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 122 ARTHROCARE CORP : TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 123 ARTHROCARE CORP : TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 124 ATRICURE INC. : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 125 ATRICURE INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 126 BOSTON SCIENTIFIC CORP : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 127 BOSTON SCIENTIFIC CORP : TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 128 BOSTON SCIENTIFIC CORP : TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 129 BSD MEDICAL CORP : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 130 C.R. BARD INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 131 C.R. BARD INC. : TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 132 C.R. BARD INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 133 CONMED CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 134 CONMED CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 135 CONMED CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 136 COVIDIEN PLC : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 137 COVIDIEN PLC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 138 COVIDIEN PLC: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 139 ELEKTA AB: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 140 ELEKTA AB : TOTAL REVENUES, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 141 ELEKTA AB: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 142 MEDTRONIC INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 143 MEDTRONIC INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)    
TABLE 144 MEDTRONIC INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 145 MISONIX INC. : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 146 MISONIX INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 147 MISONIX INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 148 OLYMPUS CORP : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 149 OLYMPUS CORP : TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 150 OLYMPUS CORP : TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 151 SMITH & NEPHEW: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 152 SMITH & NEPHEW: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 153 SMITH & NEPHEW: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 154 ST. JUDE MEDICAL INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 155 ST. JUDE MEDICAL INC: TOTAL REVENUES, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 156 ST. JUDE MEDICAL INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
TABLE 157 UROLOGIX INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 158 UROLOGIX INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 159 VARIAN MEDICAL SYSTEMS INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)    
TABLE 160 VARIAN MEDICAL SYSTEMS INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)    
TABLE 161 VARIAN MEDICAL SYSTEMS INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)    
     
     
LIST OF FIGURES     
     
FIGURE 1 GLOBAL THERMAL ABLATION TECHNOLOGIES MARKET, 2011 VS. 2016    
FIGURE 2 GLOBAL NON-THERMAL ABLATION TECHNOLOGIES MARKET, 2011 VS. 2016    
FIGURE 3 GRAPHICAL RANKING OF TOTAL ABLATION MARKET    
FIGURE 4 ABLATION TECHNOLOGIES MARKET SEGMENTATION    
FIGURE 5 MARKET SEGMENTATION OF ABLATION TECHNOLOGIES, BY APPLICATION    
FIGURE 6 MARKET DYNAMICS    
FIGURE 7 MARKET SHARE ANALYSIS, BY PLAYERS, 2011    
FIGURE 8 MARKET SHARE OF ABLATION DEVICES MARKET, BY CLINICAL APPLICATION, IN 2011    
FIGURE 9 STRATEGIES EMPLOYED BY MARKET PLAYERS IN CANCER ABLATION MARKET, JANUARY 2000 – MARCH 2012    
FIGURE 10 TECHNOLOGIES FOCUSED BY MARKET PLAYERS FOR LAUNCHED PRODUCTS, JANURAY 2000 – MARCH 2012    
FIGURE 11 TECHNOLOGIES FOCUSED BY MARKET PLAYERS FOR PRODUCTS IN PIPELINE, JANUARY 2009 – MARCH 2012    
FIGURE 12 SHARE OF VARIOUS CARDIAC ABLATION PROCEDURES, 2011    
FIGURE 13 STRATEGIES EMPLOYED BY THE MARKET PLAYERS IN THE CARDIAC ABLATION FIELD, JANUARY 2000 – MARCH 2012    
FIGURE 14 MARKET SHARE OF ABLATION DEVICES, BY GEOGRAPHY, 2011    
FIGURE 15 KEY GROWTH STRATEGIES, JANUARY 2000 – MARCH 2012    
FIGURE 16 KEY PLAYERS FOCUSING ON MERGER & ACQUISITION STRATEGY, JANUARY 2000 – MARCH 2012    
FIGURE 17 KEY PLAYERS FOCUSING ON PARTNERSHIPS & ALLIANCES STRATEGY, JANUARY 2000 – MARCH 2012    
FIGURE 18 KEY PLAYERS FOCUSING ON NEW PRODUCT LAUNCH STRATEGY, JANUARY 2000 – MARCH 2012    
FIGURE 19 KEY PLAYERS FOCUSING ON PRODUCTS IN PIPELINE, JANUARY 2009 - MARCH 2012


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 1155
Published ON
Dec, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Ablation Technologies Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved